Vous êtes ici: Home > Therapeutics (ancienne) > Cannabis and Eicosanoids: A Review of Molecular Pharmacology

J Cannabis Ther 2001(1):071-83

Eicosanoids

Cannabis and Eicosanoids: A Review of Molecular Pharmacology

Author
J.M. McPartland

Abstract
Many constituents of cannabis exhibit beneficial anti-inflammatory properties, such as delta-9-tetrahydrocannabinol (THC) in marijuana and gamma-linolenic acid (GLA) in hemp seed oil. The effects of these cannabis constituents on eicosanoid metabolism is reviewed. THC and GLA modulate the arachidonic acid cascade, inhibiting the production of series 2 prostaglandins and series 4 leukotrienes. Cannabinoid receptor- as well as non-receptor-mediated signal transduction pathways appear to be involved. It is proposed that THC acts as a selective cyclooxygenase-2 (COX-2) inhibitor.

Keywords
Cannabis, cannabinoids, tetrahydrocannabinol, marijuana, anandamide, prostaglandins, thromboxanes, leukotrienes, phospholipase, cyclooxygenase, lipooxygenase

Texte intégral au format PDF ]

Events Online 2020

Toutes les informations sur les événements en ligne de l'IACM, y compris les vidéos gratuites des webinaires sous-titrées en français, sont disponibles ici.

IACM Conference 2022

La 12e conférence de l'AICM sur les cannabinoïdes en médecine se tiendra les 20 et 21 octobre 2022, en collaboration avec la SSCM à Bâle (Suisse).

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.